MedicarePartD.guide

A non-government resource built from CMS public data

TRESIBA 100 U/mL Injection, Solution

Also known as Insulin Degludec. Coverage in Connecticut, Massachusetts, Rhode Island and Vermont (CMS PDP Region 02).

1 of 11 stand-alone Part D plans in Connecticut, Massachusetts, Rhode Island and Vermont cover this drug on tier 3.

Lowest 30-day cost $45.00 at a preferred pharmacy. No plan applies a prior authorization, step therapy or quantity limit.

45 Medicare Advantage plans in CT, MA, VT do cover it

Medicare Advantage plans carry their own formularies, separate from stand-alone Part D. A patient on an MA-PD plan may have coverage even where no PDP lists the drug. CT: 5 plans · MA: 38 plans · VT: 2 plans.

Every plan that covers it

PlanTier30-day preferred90-day mailUnit costEst. 30-day fillRestrictions
Humana Premier Rx Plan (PDP)$138.60/mo premium · $0.00 deductible3Preferred Brand$45.00$125.00$9.0958—None

Cost-sharing is the initial coverage phase at a preferred pharmacy; a percentage is coinsurance of the plan’s negotiated price, and the deductible may apply first. CMS publishes a negotiated price per unit, so the 30-day fill is shown only where the plan’s own quantity limit supplies the quantity.

See coverage in all 39 regions →